4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000053
Chairman, CEO & President returned 9,985 shares (to the company)
- Chairman, CEO & President acquired 16,251 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Chairman, CEO & President | 2022-03-08 | Grant or award | +16,251 | $0.00 | $16 | 110,868 | D: show line 1 in the form |
| SAYER KEVIN R Chairman, CEO & President | 2022-03-09 | Returned to the company | −3,149 | $406.06 | $1,278,673 | 107,719 | D: show line 2 in the form |
| SAYER KEVIN R Chairman, CEO & President | 2022-03-09 | Returned to the company | −4,473 | $406.06 | $1,816,292 | 103,246 | D: show line 3 in the form |
| SAYER KEVIN R Chairman, CEO & President | 2022-03-09 | Returned to the company | −2,363 | $406.06 | $959,512 | 100,883 | D: show line 4 in the form |
Loading xslF345X03/edgardoc.xml…